These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25006223)

  • 1. Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells.
    Benoit YD; Guezguez B; Boyd AL; Bhatia M
    Clin Cancer Res; 2014 Nov; 20(21):5372-8. PubMed ID: 25006223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling in stem and cancer stem cells.
    Wend P; Holland JD; Ziebold U; Birchmeier W
    Semin Cell Dev Biol; 2010 Oct; 21(8):855-63. PubMed ID: 20837152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling in adult intestinal stem cells and cancer.
    Krausova M; Korinek V
    Cell Signal; 2014 Mar; 26(3):570-9. PubMed ID: 24308963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy.
    Li J; Ji L; Chen J; Zhang W; Ye Z
    Biomed Res Int; 2015; 2015():964842. PubMed ID: 26078973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An emerging role for Wnt and GSK3 signaling pathways in schizophrenia.
    Singh KK
    Clin Genet; 2013 Jun; 83(6):511-7. PubMed ID: 23379509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of epigenetic modulation in cancer stem cell fate.
    Deshmukh A; Binju M; Arfuso F; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2017 Sep; 90():9-16. PubMed ID: 28711634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt/β-catenin pathway.
    Fung TK; Gandillet A; So CW
    Curr Opin Hematol; 2012 Jul; 19(4):280-6. PubMed ID: 22525581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C; Zhu X
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
    Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
    Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Wnt signaling: can we safely eradicate cancer stem cells?
    Takahashi-Yanaga F; Kahn M
    Clin Cancer Res; 2010 Jun; 16(12):3153-62. PubMed ID: 20530697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Wnt signaling in colon cancer stem cells.
    de Sousa EM; Vermeulen L; Richel D; Medema JP
    Clin Cancer Res; 2011 Feb; 17(4):647-53. PubMed ID: 21159886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT unrelated activities in commercially available preparations of recombinant WNT3a.
    Cajanek L; Adlerz L; Bryja V; Arenas E
    J Cell Biochem; 2010 Dec; 111(5):1077-9. PubMed ID: 20665540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic wnt signaling promotes protein stabilization and regulates cell size.
    Acebron SP; Karaulanov E; Berger BS; Huang YL; Niehrs C
    Mol Cell; 2014 May; 54(4):663-74. PubMed ID: 24837680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3: a multifaceted kinase in Wnt signaling.
    Wu D; Pan W
    Trends Biochem Sci; 2010 Mar; 35(3):161-8. PubMed ID: 19884009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
    Fodde R; Brabletz T
    Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and regulation of glycogen synthase kinase-3 during bovine embryo development.
    Aparicio IM; Garcia-Herreros M; Fair T; Lonergan P
    Reproduction; 2010 Jul; 140(1):83-92. PubMed ID: 20427566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
    Sun X; He Y; Huang C; Ma TT; Li J
    Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.